ARCHIVES

Congress Nearing Final Action On Appropriations, But Potential GRH Cuts Leaves Outlook Unclear

This article is from The Cancer Letter archive.

Vol. 12 No. 35 | September 12, 1986

Download PDF Visit The Full Archive

Related Articles

Tough Year Seen for Cooperative Groups; Priority Payment Questioned

December 2, 1988

NCI-Approved Clinical Trials

October 27, 2006

New Drug Approval: Groups Urge FDA To Move Quickly On Herceptin Approval

September 18, 1998

B.J. Kennedy, “Father of Medical Oncology,” Dead At 81

April 18, 2003

AstraZeneca To Pay $335M In Illegal Pricing Penalties.

June 27, 2003

National Action Plan: Return $14 Million To NCI, Committee Tells Shalala

February 14, 1997